News | December 29, 2020

Top News Stories in 2020 From the European Society of Cardiology

ESC press releases that made the most headlines

Coffee and tea are good for your heart, heart healthy. Top News Stories in 2020 From the European Society of Cardiology

December 29, 2020 — Here is a list of the top 10 news stories from the European Society of Cardiology (ESC) in 2020 that generated the most media coverage worldwide.

ESC said COVID-19 has dominated the news this year. Nevertheless, cardiovascular disease remains the world’s leading cause of death. Lifestyle issues were popular in 2020, as reflected in the latest science from ESC journals and ESC Congress. New treatments made headlines, as did the ESC’s first recommendations on sports and physical activity in people with heart disease.

The top 10 ESC news stories were:

1. Tea drinkers live longer (European Journal of Preventive Cardiology)

2. Burnout linked with irregular heartbeat (European Journal of Preventive Cardiology)

3. How to make the healthiest coffee during COVID-19 lockdown (European Journal of Preventive Cardiology)

4. Chocolate is good for the heart (European Journal of Preventive Cardiology)

5. Long naps may be bad for health (ESC Congress 2020)

6. Belly fat linked with repeat heart attacks (European Journal of Preventive Cardiology)

7. DAPA-CKD trial meets primary endpoint in patients with chronic kidney disease (ESC Congress 2020 Hot Line)

8. EMPEROR-Reduced meets primary endpoint in heart failure with reduced ejection fraction (ESC Congress 2020 Hot Line)

9. Body mass index is a more powerful risk factor for diabetes than genetics (ESC Congress 2020)

10. Can people with heart disease exercise safely? (ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease; ESC Congress 2020)

 

Related Content:

Top 25 Stories in Cardiology in 2020

Top 25 Cardiology Videos on DAIC in 2020

Video Demonstrations of How Cardiovascular Technology Works

Find all DAIC videos


Related Content

News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...

Home April 08, 2024
Home
Subscribe Now